Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 FUNCTIONALITY LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 PESTEL
3.2 PORTER'S FIVE FORCES MODEL
3.3 INDUSTRIAL INSIGHTS:
4 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN GENERIC DRUG PRODUCTION AND USES
5.1.2 THE SURGE IN DEMAND FOR EXCIPIENTS
5.1.3 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
5.1.4 RISING FOCUS ON ORPHAN DRUGS
5.2 RESTRAINTS
5.2.1 INCREASING REGULATORY STRINGENCY REGARDING THE APPROVAL OF DRUGS AND EXCIPIENTS
5.2.2 HIGH PRODUCTION COST
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 RISING DEMAND FOR EASE OF USE
5.3.3 RISING DISPOSABLE INCOME
5.3.4 INCREASING DEMAND FOR ALTERNATIVE ROUTES OF DELIVERY/DOSAGE FORMS
5.4 CHALLENGES
5.4.1 ASSOCIATED SIDE EFFECTS
5.4.2 SAFETY CONSIDERATION OF PHARMACEUTICAL EXCIPIENTS IN STORAGE & TRANSPORTATION
5.4.3 LACK OF NOVEL PHARMACEUTICAL PHARMACEUTICAL EXCIPIENTS
6 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY
6.1 OVERVIEW
6.2 BINDERS AND ADHESIVES
6.2.1 ORGANIC
6.2.2 INORGANIC
6.3 DISINTEGRANTS
6.3.1 ORGANIC
6.3.2 INORGANIC
6.4 COATING MATERIAL
6.4.1 ORGANIC
6.4.2 INORGANIC
6.5 COLORING AGENTS
6.5.1 ORGANIC
6.5.2 INORGANIC
6.6 SOLUBILIZERS
6.6.1 ORGANIC
6.6.2 INORGANIC
6.7 FLAVORS
6.7.1 ORGANIC
6.7.2 INORGANIC
6.8 SWEETENING AGENTS
6.8.1 ORGANIC
6.8.2 INORGANIC
6.9 DILUENTS
6.9.1 ORGANIC
6.9.2 INORGANIC
6.1 LUBRICANTS
6.10.1 ORGANIC
6.10.2 INORGANIC
6.11 BUFFERS
6.11.1 ORGANIC
6.11.2 INORGANIC
6.12 EMULSIFYING AGENTS
6.12.1 ORGANIC
6.12.2 INORGANIC
6.13 PRESERVATIVES
6.13.1 ORGANIC
6.13.2 INORGANIC
6.14 ANTIOXIDANTS
6.14.1 ORGANIC
6.14.2 INORGANIC
6.15 SORBENTS
6.15.1 ORGANIC
6.15.2 INORGANIC
6.16 SOLVENTS
6.16.1 ORGANIC
6.16.2 INORGANIC
6.17 EMOLLIENTS
6.17.1 ORGANIC
6.17.2 INORGANIC
6.18 GLIDENTS
6.18.1 ORGANIC
6.18.2 INORGANIC
6.19 CHELATING AGENTS
6.19.1 ORGANIC
6.19.2 INORGANIC
6.2 ANTIFOAMING AGENTS
6.20.1 ORGANIC
6.20.2 INORGANIC
6.21 OTHERS
7 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM
7.1 OVERVIEW
7.2 SOLID
7.2.1 PLANT
7.2.2 ANIMALS
7.2.3 SYNTHETIC
7.2.4 MINERALS
7.3 SEMI-SOLID
7.3.1 PLANT
7.3.2 ANIMALS
7.3.3 SYNTHETIC
7.3.4 MINERALS
7.4 LIQUID
7.4.1 PLANT
7.4.2 ANIMALS
7.4.3 SYNTHETIC
7.4.4 MINERALS
8 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION
8.1 OVERVIEW
8.2 ORAL EXCIPIENTS
8.3 TOPICAL EXCIPIENTS
8.4 PARENTERAL EXCIPIENTS
8.5 OTHER EXCIPIENTS
9 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DIRECT TENDER
9.2.1 COMPANY TENDER
9.2.2 TENDER THROUGH MARCH MERCHANDISER
9.3 RETAIL SALES
9.4 OTHERS
10 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
10.3 CONTRACT FORMULATORS
10.4 RESEARCH ORGANIZATION
10.5 OTHERS
11 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION
11.1 MIDDLE EAST AND AFRICA
11.1.1 SOUTH AFRICA
11.1.2 U.A.E
11.1.3 SAUDI ARABIA
11.1.4 KUWAIT
11.1.5 EGYPT
11.1.6 ISRAEL
11.1.7 REST OF MIDDLE EAST AND AFRICA
12 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 DOW
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 ROQUETTE FRÈRES.
14.2.1 COMPANY SNAPSHOT
14.2.2 COMPANY SHARE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 EVONIK
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 THE LUBRIZOL CORPORATION
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 BASF SE
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 ASHLAND (2021)
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 AVANTOR, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BENEO
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 CARGILL, INCORPORATED.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 CHEMIE TRADE
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 COLORCON
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 CRODA INTERNATIONAL PLC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.13 DFE PHARMA (SUBSIDIARY OF ROYAL FRIESLANDCAMPINA N.V)
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 KERRY GROUP PLC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENTS
14.15 MEGGLE GMBH & CO. KG
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 OMYA AG
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 PETER GREVEN GMBH & CO. KG
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 PFANSTIEHL
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA BINDERS AND ADHESIVES IN PHARMACEUTICAL EXCIPIENTS MARKETS, BY REGION, 2015-2029 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA BINDERS AND ADHESIVES IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA DISINTEGRANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA DISINTEGRANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA COATING MATERIAL IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA COATING MATERIAL IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA COLORING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA COLORING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA SOLUBILIZERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA SOLUBILIZERS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA FLAVORS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA FLAVORS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA SWEETENING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA SWEETENING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA DILUENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA DILUENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA LUBRICANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA LUBRICANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA BUFFERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA BUFFERS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA EMULSIFYING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA EMULSIFYING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA PRESERVATIVES IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA PRESERVATIVES IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA ANTIOXIDANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA ANTIOXIDANTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA SORBENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA SORBENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA SOLVENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA SOLVENTS PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA EMOLLIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA EMOLLIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA GLIDENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA GLIDENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA CHELATING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA CHELATING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA ANTIFOAMING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA ANTIFOAMING AGENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, FUNCTIONALITY, 2015-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA OTHERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA SEMI-SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA SEMI-SOLID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA LIQUID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA LIQUID IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DOSAGE FORM, 2015-2029 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2029 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA ORAL EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA TOPICAL EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA PARENTERAL EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA OTHER EXCIPIENTS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA DIRECT TENDER IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA DIRECT TENDER IN PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA RETAIL SALES IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA OTHERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2015-2029 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA CONTRACT FORMULATORS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA RESEARCH ORGANIZATION AND ACADEMICS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA OTHERS IN PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2015-2029 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 12 THE RISE IN GENERIC DRUG PRODUCTION AND TECHNOLOGICAL FOCUS ON PHARMACEUTICAL EXCIPIENTS IS DRIVING THE MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 THE BINDERS AND ADHESIVES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET
FIGURE 15 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, 2021
FIGURE 16 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, 2022-2029 (USD MILLION)
FIGURE 17 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, CAGR (2022-2029)
FIGURE 18 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY FUNCTIONALITY, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, 2021
FIGURE 20 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, 2022-2029 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, CAGR (2022-2029)
FIGURE 22 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2021
FIGURE 24 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)
FIGURE 26 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 28 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 30 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, 2021
FIGURE 32 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, 2022-2029 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, CAGR (2022-2029)
FIGURE 34 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET : BY END USER, LIFELINE CURVE
FIGURE 35 MIDDLE EAST AND AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: SNAPSHOT (2021)
FIGURE 36 MIDDLE EAST AND AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2021)
FIGURE 37 MIDDLE EAST AND AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 MIDDLE EAST AND AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 MIDDLE EAST AND AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: BY FUNCTIONALITY (2022-2029)
FIGURE 40 MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY SHARE 2021 (%)
